Impact News +++ Full Truck Alliance Co. Ltd. Announces Second Quarter 2025 Unaudited Financial Results (PR Newswire) +++ FULL TRUCK ALLIANCE Aktie -6,22%

IZOTROPIC Aktie

>IZOTROPIC Aktienkurs

0.184 EUR (Tradegate)

Ask: 0.1945 EUR / 5142 Stück

Bid: 0.1735 EUR / 5765 Stück

Tagesumsatz: 0 Stück

Realtime Kurs von 8 bis 22 Uhr!

IZOTROPIC Aktie über LYNX handeln

Intraday

1 Jahr

>IZOTROPIC Performance

1 Woche: +1,0%

1 Monat: +18,5%

3 Monate: -2,3%

6 Monate: -3,0%

1 Jahr: +226,4%

laufendes Jahr: +171,8%

>IZOTROPIC Aktie

Name:

IZOTROPIC CORP.

Land:

Kanada

Sektor:

Gesundheit

ISIN/ Wkn:

CA46604F1099 / A2JNLV

Symbol/ Ticker:

1R3 (Frankfurt)

Kürzel:

FRA:1R3, ETR:1R3, 1R3:GR

Index:

Webseite:

https://izocorp.com/

Profil:

Izotropic Corp is a company focused on developing ..
>Volltext..

Marktkapitalisierung:

11.42 Mio. EUR

Unternehmenswert:

12.62 Mio. EUR

Umsatz:

EBITDA:

-0.69 Mio. EUR

Nettogewinn:

-1.23 Mio. EUR

Gewinn je Aktie:

-0.02 EUR

Schulden:

1.2 Mio. EUR

Liquide Mittel:

0.13 Mio. EUR

Operativer Cashflow:

-0.25 Mio. EUR

Bargeldquote:

0.04

Umsatzwachstum:

Gewinnwachstum:

28.31%

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

Suchwörter:

IZOTROPIC

Letzte Datenerhebung:

21.08.25

>IZOTROPIC Kennzahlen

Aktien/ Unternehmen:

Aktien: 60.55 Mio. St.

Frei handelbar: 90.24%

Leerverk. Aktien: -

Rückkaufquote: -3.08%

Mitarbeiter: -

Umsatz/Mitarb.: -

Analysten:

Analystenrating: Neutral

Kursziel: -

Bewertung:

KGV: -

KGV lG: -

KUV: -

KBV: -

PEG-Ratio: -

EV/EBITDA: -

Rentabilität:

Bruttomarge: -

Gewinnmarge: -

Operative Marge: -

Managementeffizenz:

Gesamtkaprendite: -576.87%

Eigenkaprendite: -

>IZOTROPIC Peer Group

Es sind 185 Aktien bekannt.

>IZOTROPIC Chart & Kurs - Tradegate

>IZOTROPIC News

19.08.25 - 14:03

BreastCT.com Debuts as Go-To Resource for Breast CT Technology & Izotropic′s IzoView Device (GlobeNewswire EN)

VANCOUVER, British Columbia, and SACRAMENTO, Calif., Aug. 19, 2025 (GLOBE NEWSWIRE) -- via IBN – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) (“Izotropic”, or the “Company”), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of breast cancers, announces the launch of BreastCT.com, a new online platform supporting the Company's awareness initiatives....

12.08.25 - 14:06	Izotropic Corporation: Izotropic Introduces New Corporate Website & Brand Identity (Newsfile)
	Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - August 12, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical d......

05.08.25 - 14:03	Izotropic′s IzoView Positioned to Capitalize on Key Global Breast Imaging Market Drivers (GlobeNewswire EN)
	- Global breast imaging market projected to reach $8.69 billion by 2030, with IzoView addressing key clinical and commercial trends driving demand...

15.07.25 - 14:06	Izotropic Corporation: Izotropic Prepares New Platforms to Educate and Engage (Newsfile)
	- Strategic awareness initiatives underway ahead of IzoView commercialization -- Company podcast and breasct.com website in development to expand engagement -- Market-facing activities aligned wit......

13.06.25 - 14:12	Izotropic Corporation: Izotropic Provides Marketing Update (Newsfile)
	Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - June 13, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical devi......

10.06.25 - 14:06	Izotropic Corporation: Izotropic Revises License Agreement with The Regents of the University of California (Newsfile)
	- License agreement enables U.S. FDA approval or foreign equivalent (CE mark) -- Amendment aligns with Company's timelines for IzoView product launch -- Agreement amendment fees of USD $85K payabl......

20.05.25 - 21:51	Corporate News: Izotropic Corporation (EQS)
	FDA-Zulassungsverfahren von Izotropic genehmigt – Unternehmen gibt Update...

17.05.25 - 04:42	Izotropic Corporation: Izotropic′s U.S. FDA Regulatory Pathway Greenlit, Company Provides Corporate Update (Newsfile)
	- Regulatory alignment with FDA confirmed, clearing path to pivotal U.S. clinical trial -- 150-page strategic business plan and advanced financial models completed -- Investor outreach launched to......

02.04.25 - 21:48	Izotropic Corporation: Izotropic Engages International Communications Consultant, Grants Incentive Stock Options & RSUs to Key Personnel, Amends Promissory Note with Primary Lender (Newsfile)
	Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - April 2, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical devi......

25.03.25 - 13:06	Izotropic Corporation: Izotropic Completes Pre-Submission Meeting with FDA for Breast Cancer Screening Indication (Newsfile)
	- FDA meeting facilitated positive collaborative exchange -- Key topics included the clinical study protocol synopsis, the benefits versus risks of contrast-enhancement, and the management of brea......

10.03.25 - 13:06	Izotropic Corporation: Izotropic to Present at Investor Conference March 13th (Newsfile)
	- CEO to discuss IzoView's competitive advantage, expansion strategy, and potential revenue models -- Event includes live Q and A, attendance is complimentary -- Individual and institutional inves......

19.02.25 - 14:06	Izotropic Corporation: FDA Sets Meeting Date with Izotropic (Newsfile)
	Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - February 19, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical ......

14.02.25 - 14:06	Izotropic Corporation: Izotropic Closes Non-Brokered Private Placement (Newsfile)
	Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - February 14, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical ......

07.02.25 - 15:06	Izotropic Corporation: Izotropic Announces Non-Brokered Private Placement (Newsfile)
	THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATESVancouver, British Columbia and Sacramento, California--(Newsfile Corp. - February 7, 2025......

06.02.25 - 02:42	Izotropic Corporation: Izotropic Reschedules Investor Conference Presentation to March 13th (Newsfile)
	Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - February 5, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical d......

03.02.25 - 14:13	Izotropic Corporation: Izotropic to Present at Investor Conference February 6th (Newsfile)
	- CEO to present overview of Company value proposition, unique catalysts, and near-term objectives -- Event includes live Q and A, attendance is complimentary -- Individual and institutional inves......

29.01.25 - 14:06	Izotropic Corporation: Izotropic Announces Timelines and Milestones to IzoView Product Launch (Newsfile)
	- Unique dense breast tissue focus to drive expedited recruitment rates; modular clinical study design reduces time to PMA submission by ~6 months -- 3 Site U.S.-based clinical study enables early......

17.01.25 - 14:06	Izotropic Corporation: Izotropic Featured in Announcement of Research and Markets′ U.S. Breast Cancer Analysis and Forecast (Newsfile)
	- Company listed in Research and Markets' announcement and description of new research report on the U.S. Breast Cancer Screening and Diagnostic Market- - "U.S. breast cancer screening and diagnos......

15.01.25 - 14:06	Izotropic Corporation: Izotropic Announces Team Leading Clinical Study Design and FDA Regulatory Submissions (Newsfile)
	-New FDA Consultant is the former Director of the Division of Imaging, Diagnostics, and Software Reliability at the U.S Food and Drug Administration--New Biostatistical Consultant is the former De......

09.01.25 - 14:06	Izotropic Corporation: Izotropic Files Pre-Submission with U.S. FDA for Breast Cancer Screening (Newsfile)
	-A screening indication for women with dense breast tissue adjunctive to 3D mammography increases the market size for annual IzoView scans by over 800%1 for initial approval and product launch- -R......

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Nur übereilt bestimmt die Neigung sich. - Johann Wolfgang von Goethe

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram